| HOME >> BIOLOGY >> TECHNOLOGY |
'They've gotten the science wrong. They've gotten the law wrong. Why should
we trust them to get cures right?'
ST. LOUIS, Sept. 5 /PRNewswire-USNewswire/ -- Missouri Coalition for Lifesaving Cures responded today as opponents of stem cell cures refiled their measure yet again, the third time in less than 2 weeks.
Said Donn Rubin, Chair of Missouri Coalition for Lifesaving Cures, "In their zeal to repeal stem cell research and criminalize doctors who pursue desperately needed cures, opponents of stem cell research have trampled both basic science and basic law. First their deceptive and far-reaching initiative would have excluded Missourians with common chromosomal abnormalities like Downs, Klinefelter and Turner syndromes from their definition of 'human.' Then their 'improved' initiative would have made their supporters' e-mail addresses part of the public record, opening them up to spammers and scammers. They simply can't get their act together. We shouldn't trust anything they put on the ballot."
Added Rubin, "Whether it's little errors or big ones, this initiative's supporters can't get anything right. But no matter how many times they rewrite and refile their initiative, their intent is the same: to repeal the stem cell measure passed by voters less than nine months ago."
Thanks to Missouri's passage of the Stem Cell Amendment last year, Missouri's constitution now guarantees equal access to stem cell research, treatment and cures allowed under federal law and available to other Americans. It also makes any attempt to clone a human being a felony crime, punishable by up to 15 years in prison and a $250,000 fine. The proposed initiative's plan to redefine stem cell research as "cloning" is really a disguised attempt to repeal the stem cell guarantees established by voters last year.
Missouri Coalition for Lifesaving Cures promotes cures for diseases
such as Parkinson's and diabetes in Missouri. It is a gras
'/>"/>
| SOURCE Missouri Coalition for Lifesaving Cures Copyright©2007 PR Newswire. All rights reserved |